Yüklüyor......
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
OBJECTIVE: Prevention trials for neurodegenerative diseases use genetic or other risk marker tests to select participants but there is concern that this could involve coercive disclosure of unwanted information. This has led some trials to use blinded enrollment (participants are tested but not told...
Kaydedildi:
| Yayımlandı: | Neurology |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4395889/ https://ncbi.nlm.nih.gov/pubmed/25762713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001451 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|